The role of gut microbiome in aging-associated diseases: where do we stand now and how technology will transform the future
Open Access
- 27 December 2025
- journal article
- review article
- Published by Taylor & Francis in Gut Microbes
- Vol. 18 (1) , 2607076
Abstract
The gut microbiome has emerged as a critical regulator of human aging and healthspan, with age-related dysbiosis increasingly implicated in a broad spectrum of aging-associated diseases. This review synthesizes evidence linking gut microbial alterations to infectious diseases, antimicrobial resistance, autoimmune, neurodegenerative, psychiatric, cancer, metabolic, kidney, cardiovascular, bone, and muscular diseases, highlighting shared mechanisms such as chronic inflammation, immune dysregulation, and metabolite imbalance. We further explore how enabling technologies, including functional multi-omics, synthetic biology, artificial intelligence-driven analytics, biobanking, and autologous fecal microbiota transplantation, are revolutionizing microbiome research and the design of interventions. Ethical considerations surrounding microbiome-based therapies are also addressed. To translate these scientific insights into clinical innovations, we formulate the PRIME framework: a five-phase roadmap encompassing Profiling, Reviewing, Identifying, Mapping, and Evaluating microbiome-based interventions. By integrating microbiome science, aging biology, and emerging technologies, this review provides a comprehensive blueprint for advancing precision medicine and promoting healthy aging. Furthermore, it emphasizes the importance of building future-ready capabilities to navigate the evolving landscape of age-related diseases and microbiome-driven therapeutic innovations.Keywords
Funding Information
- Hevolution Foundation (HF-KSA 005 (NRC23R-467-08))
This publication has 409 references indexed in Scilit:
- Social Isolation and Loneliness in Older AdultsJAMA, 2024
- Associations of the Gut Microbiome With Treatment Resistance in SchizophreniaJAMA Psychiatry, 2024
- Psychiatric Disorders Before and After Dementia DiagnosisJAMA Network Open, 2023
- Human gut microbiome: Therapeutic opportunities for metabolic syndrome—Hype or hope?Endocrinology, Diabetes & Metabolism, 2023
- Aging characteristics of colorectal cancer based on gut microbiotaCancer Medicine, 2023
- The role of RNA regulators, quorum sensing and c‐di‐GMP in bacterial biofilm formationFEBS Open Bio, 2022
- The ever‐increasing importance of cancer as a leading cause of premature death worldwideCancer, 2021
- Biosensing in Smart Engineered ProbioticsBiotechnology Journal, 2019
- Gut microbiome in type 1 diabetes: A comprehensive reviewDiabetes/Metabolism Research and Reviews, 2018
- Commensal Gram‐negative bacteria prime human dendritic cells for enhanced IL‐23 and IL‐27 expression and enhanced Th1 developmentEuropean Journal of Immunology, 2004